发明名称 Methods for the Diagnosis and Treatment of Neurological and Neurodegenerative Diseases, Disorders and Associated Processes
摘要 The invention generally relates to methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders, and associated processes. Specifically, the present invention is directed toward methods to determine prognosis, diagnosis or efficacy of a therapeutic regimen by using a detectable label to measure levels of alpha-synuclein.
申请公布号 US2016313353(A1) 申请公布日期 2016.10.27
申请号 US201615178419 申请日期 2016.06.09
申请人 C2N Diagnostics 发明人 West Tim;Paoletti Andrew C.
分类号 G01N33/68 主分类号 G01N33/68
代理机构 代理人
主权项 1. A method to determine the prognosis, diagnosis, efficacy of a therapeutic regimen, or predict subject response to a therapeutic agent to treat an alpha-synuclein related disease or disorder in a subject comprising contacting a biological sample from a subject with a labeled moiety to detect the level of alpha-synuclein in the sample wherein the level is compared with a reference standard level, wherein a difference in the level in the sample as compared to the reference level allows one to determine the prognosis, diagnosis, efficacy of the therapeutic regimen or predict subject response to a therapeutic agent to treat an alpha-synuclein related disease or disorder.
地址 Saint Louis MO US